Search Results - "Stella, Peter"
-
1
More Similarities Than Differences Testing Insulin Glargine 300 Units/mL Versus Insulin Degludec 100 Units/mL in Insulin-Naive Type 2 Diabetes: The Randomized Head-to-Head BRIGHT Trial
Published in Diabetes care (01-10-2018)“…To compare insulin glargine 300 units/mL (Gla-300) versus insulin degludec 100 units/mL (IDeg-100) in this first head-to-head randomized controlled trial…”
Get full text
Journal Article -
2
Empagliflozin as Add-on Therapy to Pioglitazone With or Without Metformin in Patients With Type 2 Diabetes Mellitus
Published in Clinical therapeutics (01-08-2015)“…Abstract Purpose To investigate the long-term efficacy and safety of empagliflozin as add-on therapy to pioglitazone with or without metformin in patients with…”
Get full text
Journal Article -
3
A validated, real-time prediction model for favorable outcomes in hospitalized COVID-19 patients
Published in NPJ digital medicine (06-10-2020)“…The COVID-19 pandemic has challenged front-line clinical decision-making, leading to numerous published prognostic tools. However, few models have been…”
Get full text
Journal Article -
4
Quantitative coronary angiography in the current era: principles and applications
Published in Journal of interventional cardiology (01-12-2009)“…Coronary angiography, despite its inherent invasiveness and need for contrast media and radiographic exposure, is still routinely employed every year for the…”
Get more information
Journal Article -
5
The effect of concomitant DPPIVi use on glycaemic control and hypoglycaemia with insulin glargine 300 U/mL (Gla-300) versus insulin glargine 100 U/mL (Gla-100) in people with type 2 diabetes: A patient-level meta-analysis of EDITION 2 and 3
Published in PloS one (01-01-2018)“…To evaluate the effect of concomitant dipeptidyl peptidase IV inhibitor (DPPIVi) use on efficacy and safety of insulin glargine 300 U/mL (Gla-300) versus…”
Get full text
Journal Article -
6
Validation of parsimonious prognostic models for patients infected with COVID-19
Published in BMJ health & care informatics (03-09-2021)“…ObjectivesPredictive studies play important roles in the development of models informing care for patients with COVID-19. Our concern is that studies producing…”
Get full text
Journal Article -
7
Urinary NGAL Marks Cystic Disease in HIV-Associated Nephropathy
Published in Journal of the American Society of Nephrology (01-08-2009)“…Nephrosis and a rapid decline in kidney function characterize HIV-associated nephropathy (HIVAN). Histologically, HIVAN is a collapsing focal segmental…”
Get full text
Journal Article -
8
-
9
Interpreting Modern Monetary Reality
Published in Journal of Applied Corporate Finance (01-12-2021)“…During the 1990s and 2000s, the quantity theory of money (QTM) fell out of favor both among policymakers and academics. Central bankers almost universally…”
Get full text
Journal Article -
10
-
11
Effectiveness of Insulin Glargine U300 Used as Part of Basal Bolus Therapy in People with T2DM—Toujeo 6 Months Real-World Data From Hungary
Published in Diabetes (New York, N.Y.) (01-07-2018)“…The EDITION program demonstrated similar efficacy with lower risk of hypoglycemia (HG) of insulin glargine U300 (Gla-300) compared to insulin glargine U100 in…”
Get full text
Journal Article -
12
Abdominal aortic embolization of a Figulla atrial septum occluder device, at the level of the celiac axis, after an atrial septal defect closure: hybrid attempt
Published in Vascular (01-02-2010)“…A 41-year-old woman was treated with a Figulla (Occlutec, Helsingborg, Sweden) atrial septum occluder device with no intraprocedural complications. Five months…”
Get more information
Journal Article -
13
637-P: Effectiveness of Fixed Ratio Combination of IGlarLixi in People with Type 2 Diabetes Mellitus: Experience from Routine Clinical Practice
Published in Diabetes (New York, N.Y.) (01-06-2021)“…Background: Currently no data are available on the real-world effectiveness of the fixed ratio combination of insulin glargine 100 U/ml and lixisenatide…”
Get full text
Journal Article -
14
The IDEAL (Insulin therapy DE-intensificAtion with iglarLixi) Randomised Controlled Trial—Study Design and Protocol
Published in Diabetes therapy (01-06-2024)“…Introduction Multiple daily injection insulin regimen (MDI) represents the most intensive insulin regimen used in the management of people with type 2 diabetes…”
Get full text
Journal Article -
15
Insulin Glargine 300 U/mL and Insulin Glulisine Treatment in Patients with Type 2 Diabetes: A Non-Interventional Study of Effectiveness in Routine Clinical Practice
Published in Diabetes therapy (01-02-2020)“…Introduction The EDITION development program confirmed that insulin glargine 300 U/mL (Gla-300) provides comparable glycemic control to insulin glargine…”
Get full text
Journal Article -
16
Glycaemic control and hypoglycaemia burden in patients with type 2 diabetes initiating basal insulin in Europe and the USA
Published in Diabetes, obesity & metabolism (01-08-2017)“…Aims To evaluate short‐ and long‐term glycaemic control and hypoglycaemia incidence in insulin‐naïve patients ≥30 years of age with type 2 diabetes (T2DM)…”
Get full text
Journal Article -
17
Prediction of Resuscitation for Pediatric Sepsis from Data Available at Triage
Published in AMIA ... Annual Symposium proceedings (2021)“…Pediatric sepsis imposes a significant burden of morbidity and mortality among children. While the speedy application of existing supportive care measures can…”
Get full text
Journal Article -
18
1105-P: Impact of Switching from Twice-Daily Basal Insulin (BI) to Once-Daily Insulin Glargine 300 U/mL (Gla-300) in Patients with Type 1 Diabetes (T1DM): Phase 4 Optimize Study
Published in Diabetes (New York, N.Y.) (01-06-2019)“…The 28-week, prospective, multicenter, open-label OPTIMIZE study, conducted in Belgium (presented at ADA 2018) and Canada, evaluated treatment optimization…”
Get full text
Journal Article -
19
Deferral vs. performance of percutaneous coronary intervention of functionally non-significant coronary stenosis: 15-year follow-up of the DEFER trial
Published in European heart journal (01-12-2015)“…Stenting an angiographically intermediate but functionally non-significant stenosis is controversial. Nevertheless, it has been questioned if deferral of a…”
Get full text
Journal Article Web Resource -
20
Impact of Switching from Twice-Daily Basal Insulin to Once-Daily Insulin Glargine 300 U/mL (Gla-300) in Patients with Type 1 Diabetes (T1DM)—Phase 4 OPTIMIZE Study, Belgian Cohort
Published in Diabetes (New York, N.Y.) (01-07-2018)“…The 28-week, prospective, multicenter, open-label OPTIMIZE study, conducted in Belgium and Canada, evaluated treatment optimization with once-daily (OD)…”
Get full text
Journal Article